BACKGROUND: The molecular mechanisms underlying innate fear are poorly understood. Previous studies indicated that the acid sensing ion channel ASIC1a influences fear behavior in conditioning paradigms. However, these differences may have resulted from an ASIC1a effect on learning, memory, or the expression of fear. METHODS: To test the hypothesis that ASIC1a influences the expression of fear or anxiety independent of classical conditioning, we examined the effects of disrupting the mouse ASIC1a gene on unconditioned fear in the open field test, unconditioned acoustic startle, and fear evoked by the predator odor trimethylthiazoline (TMT). In addition, we tested the effects of acutely inhibiting ASIC1a with PcTx, an ASIC1a antagonist in tarantula venom. Our immunohistochemistry suggested ASIC1a is expressed in the bed nucleus of the stria terminalis, medial amygdala, and periaqueductal gray, which are thought to play important roles in the generation and expression of innate fear. Therefore, we also tested whether ASIC1a disruption altered c-fos expression in these structures following TMT exposure. RESULTS: We found that the loss of ASIC1a reduced fear in the open field test, reduced acoustic startle, and inhibited the fear response to TMT. Similarly, intracerebroventricular administration of PcTx reduced TMT-evoked freezing in ASIC1a(+/+) mice but not ASIC1a(-/-) mice. In addition, loss of ASIC1a altered TMT-evoked c-fos expression in the medial amydala and dorsal periaqueductal gray. CONCLUSIONS: These findings suggest that ASIC1a modulates activity in the circuits underlying innate fear. Furthermore, the data indicate that targeting the ASIC1a gene or acutely inhibiting ASIC1a suppresses fear and anxiety independent of conditioning.
BACKGROUND: The molecular mechanisms underlying innate fear are poorly understood. Previous studies indicated that the acid sensing ion channel ASIC1a influences fear behavior in conditioning paradigms. However, these differences may have resulted from an ASIC1a effect on learning, memory, or the expression of fear. METHODS: To test the hypothesis that ASIC1a influences the expression of fear or anxiety independent of classical conditioning, we examined the effects of disrupting the mouseASIC1a gene on unconditioned fear in the open field test, unconditioned acoustic startle, and fear evoked by the predator odor trimethylthiazoline (TMT). In addition, we tested the effects of acutely inhibiting ASIC1a with PcTx, an ASIC1a antagonist in tarantula venom. Our immunohistochemistry suggested ASIC1a is expressed in the bed nucleus of the stria terminalis, medial amygdala, and periaqueductal gray, which are thought to play important roles in the generation and expression of innate fear. Therefore, we also tested whether ASIC1a disruption altered c-fos expression in these structures following TMT exposure. RESULTS: We found that the loss of ASIC1a reduced fear in the open field test, reduced acoustic startle, and inhibited the fear response to TMT. Similarly, intracerebroventricular administration of PcTx reduced TMT-evoked freezing in ASIC1a(+/+) mice but not ASIC1a(-/-) mice. In addition, loss of ASIC1a altered TMT-evoked c-fos expression in the medial amydala and dorsal periaqueductal gray. CONCLUSIONS: These findings suggest that ASIC1a modulates activity in the circuits underlying innate fear. Furthermore, the data indicate that targeting the ASIC1a gene or acutely inhibiting ASIC1a suppresses fear and anxiety independent of conditioning.
Authors: Scott D Kuduk; Christina N Di Marco; Vera Bodmer-Narkevitch; Sean P Cook; Matthew J Cato; Aneta Jovanovska; Mark O Urban; Michael Leitl; Nova Sain; Annie Liang; Robert H Spencer; Stefanie A Kane; George D Hartman; Mark T Bilodeau Journal: ACS Chem Neurosci Date: 2009-10-06 Impact factor: 4.418
Authors: Erin N Hoagland; Thomas W Sherwood; Kirsten G Lee; Christopher J Walker; Candice C Askwith Journal: J Biol Chem Date: 2010-10-29 Impact factor: 5.157
Authors: Jordan W Smoller; Patience J Gallagher; Laramie E Duncan; Lauren M McGrath; Stephen A Haddad; Avram J Holmes; Aaron B Wolf; Sidney Hilker; Stefanie R Block; Sydney Weill; Sarah Young; Eun Young Choi; Jerrold F Rosenbaum; Joseph Biederman; Stephen V Faraone; Joshua L Roffman; Gisele G Manfro; Carolina Blaya; Dina R Hirshfeld-Becker; Murray B Stein; Michael Van Ameringen; David F Tolin; Michael W Otto; Mark H Pollack; Naomi M Simon; Randy L Buckner; Dost Ongür; Bruce M Cohen Journal: Biol Psychiatry Date: 2014-01-18 Impact factor: 13.382
Authors: Jeanne E Savage; Omari McMichael; Eugenia I Gorlin; Jessica R Beadel; Bethany Teachman; Vladimir I Vladimirov; John M Hettema; Roxann Roberson-Nay Journal: Biol Psychol Date: 2015-04-22 Impact factor: 3.251
Authors: Roxanne Y Walder; Lynn A Rasmussen; Jon D Rainier; Alan R Light; John A Wemmie; Kathleen A Sluka Journal: J Pain Date: 2009-12-16 Impact factor: 5.820
Authors: Michael Koenigs; Edward D Huey; Vanessa Raymont; Bobby Cheon; Jeffrey Solomon; Eric M Wassermann; Jordan Grafman Journal: Nat Neurosci Date: 2007-12-23 Impact factor: 24.884
Authors: Xiang-ming Zha; Runping Wang; Dan M Collier; Peter M Snyder; John A Wemmie; Michael J Welsh Journal: Proc Natl Acad Sci U S A Date: 2009-02-13 Impact factor: 11.205